Medical Comorbidity & C-L Psychiatry at AAPP 2027 Annual Meeting

5 sessions on medical comorbidity & c-l psychiatry · April 4–7, 2027, Louisville, KY. Compare medical comorbidity & c-l psychiatry at other meetings →

Monday, April 5

  • 08:00–09:00 · Lecture · Clinical Application Series

    Mental Health Care in Oncology: Highlighting a Lived Experience

    Kelly N. Gable

    A session drawing on a patient's lived experience and current evidence to examine anxiety, depression and distress in people with cancer. It covers barriers to integrated mental health care and the psychiatric pharmacist's role in supporting patients, including menopause related to cancer treatment.

    Anxiety Disorders · Collaborative & Integrated Care · Depression

  • 14:50–15:50 · Lecture · Clinical Application Series

    Neuropsychiatric Comorbidities of Multiple Sclerosis

    Michelle Rainka

    Covers how common psychiatric symptoms present in people with multiple sclerosis and reviews the safety and efficacy of pharmacologic options given limited evidence. Focuses on choosing individualized treatment regimens for co-occurring psychiatric symptoms.

    Drug Interactions & Safety

Tuesday, April 6

  • 12:20–13:20 · Lecture · Clinical Application Series

    Managing Psychiatric Symptoms in Neurogenetic Syndromes

    Lauren Leiby

    Reviews psychiatric and behavioral symptoms seen in neurogenetic syndromes and the evidence for pharmacologic treatment, including emerging options. Covers safety, ethical considerations and building patient-centered, stewardship-oriented treatment plans.

    Autism & Neurodevelopmental Disorders · Child & Adolescent · Pharmacogenomics & Precision Psychiatry

  • 13:30–14:30 · Lecture · Clinical Application Series

    Antiseizure Medications in Neuropsychiatric Practice: Identifying, Preventing, and Managing Adverse Effects

    Barry E. Gidal

    Online course on the systemic and neuropsychiatric adverse effects of antiseizure medications, covering patient-specific risk factors and strategies to prevent, identify and manage problems. Emphasizes individualized treatment plans to improve safety and adherence.

    Drug Interactions & Safety · Lithium & Mood Stabilizers

  • 14:50–15:50 · Lecture

    Testosterone Across the Male Lifespan and Implications for Mental Health

    Jeremy Daniel

    Covers how testosterone changes across a man's life and how it relates to mood, anxiety and cognition. Reviews neurotransmitter mechanisms, patient selection for screening, and the benefits, limits and risks of testosterone replacement therapy.

    Anxiety Disorders · Depression · Neuroscience & Mechanisms

Other topics at this meeting

Drug Interactions & Safety 5Practice, Policy & Workforce 5Antipsychotic Prescribing 4Anxiety Disorders 4Collaborative & Integrated Care 4Education & Training 4Schizophrenia & Psychosis 4Deprescribing & Polypharmacy 3Depression 3Measurement-Based Care & Diagnosis 3Pharmacogenomics & Precision Psychiatry 3Child & Adolescent 2

Full program overview →